NCT00103298View on ClinicalTrials.gov

Isolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

December 31, 2004

Study Completion Date

July 31, 2006

Conditions

Colorectal CancerMetastatic Cancer

Interventions

DRUG

FOLFOX regimen

DRUG

fluorouracil

DRUG

isolated perfusion

DRUG

leucovorin calcium

DRUG

melphalan

DRUG

oxaliplatin

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00103298 - Isolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer | Biotech Hunter | Biotech Hunter